Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             94 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Actinomycosis, a sheep in wolves' clothes Neijens, V.
1996
15 1 p. 131-135
5 p.
artikel
2 Activity of anti-erbB-2 recombinant toxin OLX-209 on lung cancer cell lines in the absence of erbB-2 gene amplification 1996
15 1 p. 143-
1 p.
artikel
3 A dose-response relationship between the frequency of p53 mutations and tobacco consumption in lung cancer patients 1996
15 1 p. 139-
1 p.
artikel
4 Allelic deletion mapping on chromosome 5 in human lung carcinomas 1996
15 1 p. 142-143
2 p.
artikel
5 Alpha-fetoprotein-producing adenocarcinoma of the lung Yoshino, Ichiro
1996
15 1 p. 125-130
6 p.
artikel
6 Altered cJun expression: An early event in human lung carcinogenesis 1996
15 1 p. 140-
1 p.
artikel
7 Aspects of the epidemiology of lung cancer in smokers and nonsmokers in the United States Kabat, Geoffrey C.
1996
15 1 p. 1-20
20 p.
artikel
8 Atypical adenomatous hyperplasia and adenocarcinoma of the human lung: Their heterology in form and analogy in immuno-histochemical characteristics 1996
15 1 p. 146-147
2 p.
artikel
9 Bioavailability of 50- and 75-mg oral etoposide in lung cancer patients 1996
15 1 p. 155-
1 p.
artikel
10 Bronchioloalveolar carcinoma: Computed tomography findings 1996
15 1 p. 149-
1 p.
artikel
11 Bronchogenic carcinoma: Incidence of metastases to normal sized lymph nodes 1996
15 1 p. 147-
1 p.
artikel
12 Calendar 1996
15 1 p. 137-138
2 p.
artikel
13 Carboplatin combined with amifostine, a bone marrow protectant, in the treatment of non-small-cell lung cancer: A randomised phase II study 1996
15 1 p. 152-
1 p.
artikel
14 Chromosomal 11 alterations in non-small-cell lung carcinomas in Hong Kong Chan, Andrew S.K.
1996
15 1 p. 51-65
15 p.
artikel
15 Clinical pharmacology of chronic oral etoposide in patients with small cell and non-small cell lung cancer 1996
15 1 p. 154-155
2 p.
artikel
16 Clinico-pathological features and survival of lung cancer patients in Paris, France 1996
15 1 p. 146-
1 p.
artikel
17 Combination chemotherapy with gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: Preliminary results of an ongoing phase I/II study 1996
15 1 p. 152-153
2 p.
artikel
18 Comparison of pleuropneumonectomy and limited surgery for lung cancer with pleural dissemination 1996
15 1 p. 151-
1 p.
artikel
19 Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations, and cell proliferation characteristics in non-small cell lung cancer cell lines 1996
15 1 p. 152-
1 p.
artikel
20 CYFRA 21-1 determination in patients with non-small cell lung cancer: Clinical utility for the detection of recurrences 1996
15 1 p. 147-
1 p.
artikel
21 Cytokeratin tumor marker levels in bronchial washing in the diagnosis of lung cancer 1996
15 1 p. 148-
1 p.
artikel
22 Detection of disseminated lung cancer cells in lymph nodes: Impact on staging and prognosis 1996
15 1 p. 146-
1 p.
artikel
23 Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung 1996
15 1 p. 153-
1 p.
artikel
24 Dose escalation study of carboplatin with fixed-dose etoposide plus granulocyte-colony stimulating factor in patients with small cell lung carcinoma: A study of the Lung Cancer Study Group of West Japan 1996
15 1 p. 152-
1 p.
artikel
25 Early phase II study of oral administration of etoposide for 21 consecutive days in patients with non-small-cell lung cancer 1996
15 1 p. 156-
1 p.
artikel
26 Editorial Board 1996
15 1 p. IFC-
1 p.
artikel
27 Effect of interfraction interval in hyperfractionated radiotherapy with or without concurrent chemotherapy for stage III nonsmall cell lung cancer 1996
15 1 p. 157-
1 p.
artikel
28 Etoposide and doxorubicin antagonize the in vitro activity of paclitaxel in human non-small cell lung cancer cell lines Viallet, J.
1996
15 1 p. 93-101
9 p.
artikel
29 Evaluation of the optimal duration of chemotherapy in phase II trials for inoperable non-small-cell lung cancer (NSCLC) 1996
15 1 p. 153-154
2 p.
artikel
30 Excellent survival in a subgroup of patients with intrapulmonary metastasis of lung cancer 1996
15 1 p. 150-
1 p.
artikel
31 Expression of bcl-2 — protein in small cell lung cancer Kaiser, U.
1996
15 1 p. 31-40
10 p.
artikel
32 Expression of IGF-1, TGF-α and p53 protein in imprint smears of bronchial biopsy specimens of lung cancer 1996
15 1 p. 145-
1 p.
artikel
33 Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer 1996
15 1 p. 155-156
2 p.
artikel
34 Extensive areas of aneuploidy are present in the respiratory epithelium of lung cancer patients 1996
15 1 p. 140-
1 p.
artikel
35 Fine tuning of epitopic dominance induced by lung cancer on the IgG response to bovine betalactoglobulin: Towards a paraneoplastic immune marker 1996
15 1 p. 144-145
2 p.
artikel
36 Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer 1996
15 1 p. 148-149
2 p.
artikel
37 Frequency and prognostic evaluation of 3p21–22 allelic losses in non-small-cell lung cancer 1996
15 1 p. 144-
1 p.
artikel
38 Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: Evidence for a new tumor suppressor gene on the short arm of chromosome 12 1996
15 1 p. 145-
1 p.
artikel
39 Gemcitabine: Clinical and economic impact in inoperable non-small cell lung cancer 1996
15 1 p. 153-
1 p.
artikel
40 Gingival metastasis of large-cell lung cancer that produced G-CSF 1996
15 1 p. 147-
1 p.
artikel
41 Glucocorticoid receptors and growth inhibitory effects of dexamethasone in human lung cancer cell lines 1996
15 1 p. 142-
1 p.
artikel
42 High plasma level of plasmin-α2-plasmin inhibitor complex is predictor of poor prognosis in patients with lung cancer 1996
15 1 p. 150-
1 p.
artikel
43 Hilar lymphnode metastasis of bronchogenic carcinoma; evaluation with ultrafast incremental dynamic CT (IDCT) 1996
15 1 p. 149-
1 p.
artikel
44 Histologic changes in small cell lung carcinoma after treatment 1996
15 1 p. 145-
1 p.
artikel
45 Hyperfractionated radiotherapy and concomitant cisplatin in Stage III non-small cell lung cancer: a Phase II study by the AIRO-Lombardia Cooperative Group Palazzi, Mauro
1996
15 1 p. 85-91
7 p.
artikel
46 IASLC annoucement 1996
15 1 p. 159-
1 p.
artikel
47 Immunohistochemical analysis of p53 mutations in bronchioalveolar carcinoma and conventional pulmonary adenocarcinoma 1996
15 1 p. 145-146
2 p.
artikel
48 Immunoscintigraphy of small-cell lung cancer xenografts with anti neural cell adhesion molecule monoclonal antibody, 123C3: Improvement of tumour uptake by internalisation 1996
15 1 p. 144-
1 p.
artikel
49 Intraoperative brachytherapy using gelfoam radioactive plaque implants for resected stage III non-small cell lung cancer with positive margin: A pilot study 1996
15 1 p. 156-
1 p.
artikel
50 Isolation of a polyamine transport deficient cell line from the human non-small cell lung carcinoma line NCI H157 1996
15 1 p. 141-142
2 p.
artikel
51 KM195 as an immunohistochemical marker of adenocarcinoma of the lung Kawai, Toshiaki
1996
15 1 p. 41-50
10 p.
artikel
52 Local irradiation alone for peripheral stage I lung cancer: Could we omit the elective regional nodal irradiation? 1996
15 1 p. 157-
1 p.
artikel
53 Long-term survival of patients with lung cancer from a defined geographical area before and after radiological screening Hillerdal, Gunnar
1996
15 1 p. 21-30
10 p.
artikel
54 Loss of heterozygosity at 9p21 loci and mutations of the MTS1 and MTS2 genes in human lung cancers 1996
15 1 p. 141-
1 p.
artikel
55 Lung cancer and solitary brain metastasis: Results of the combined surgical treatment 1996
15 1 p. 151-152
2 p.
artikel
56 Lung cancer in women: Selected topics in epidemiology and prevention 1996
15 1 p. 139-
1 p.
artikel
57 Lymphoid monoclonal antibodies reactive with lung tumors: Diagnostic applications 1996
15 1 p. 147-
1 p.
artikel
58 New design of N-isopropyl-p-[123I]iodoamphetamine (123I-IMP) lung imaging in the patient with lung cancer 1996
15 1 p. 147-148
2 p.
artikel
59 N1 of lung cancer evaluated by thin-section dynamic CT 1996
15 1 p. 149-
1 p.
artikel
60 Nuclear p53 overexpression is an independent prognostic parameter in node-negative non-small cell lung carcinoma 1996
15 1 p. 149-
1 p.
artikel
61 Paclitaxel plus hydroxyurea as second line therapy for non-small cell lung cancer Stewart, David J.
1996
15 1 p. 115-123
9 p.
artikel
62 Partial substitution of cisplatin with carboplatin in combination with etoposide in advanced non-small cell lung cancer (NSCLC): a multicentric randomised Phase II trial Comella, Pasquale
1996
15 1 p. 103-114
12 p.
artikel
63 Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer 1996
15 1 p. 154-
1 p.
artikel
64 P53 in squamous metaplasia: A marker for risk of respiratory tract carcinoma 1996
15 1 p. 140-
1 p.
artikel
65 p53 protein accumulation and the presence of human papillomavirus DNA in bronchiolo-alveolar carcinoma correlate with poor prognosis 1996
15 1 p. 144-
1 p.
artikel
66 p53 protein in non-small cell lung cancer as quantitated by enzyme-linked immunosorbent assay: Relation to prognosis 1996
15 1 p. 143-
1 p.
artikel
67 Prognostic factors for patients with advanced non-small cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation Takigawa, Nagio
1996
15 1 p. 67-77
11 p.
artikel
68 Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer 1996
15 1 p. 143-144
2 p.
artikel
69 Prognostic value of carcino-embryonic antigen in lung carcinoma before treatment 1996
15 1 p. 148-
1 p.
artikel
70 Pulmonary dust retention in silicotics with and without lung cancer 1996
15 1 p. 139-
1 p.
artikel
71 Putrescine accumulation in human pulmonary tumours 1996
15 1 p. 142-
1 p.
artikel
72 Radiolocalization of squamous lung carcinoma with 131I-labeled epidermal growth factor 1996
15 1 p. 143-
1 p.
artikel
73 Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis 1996
15 1 p. 155-
1 p.
artikel
74 Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: A North Central Cancer Treatment Group study 1996
15 1 p. 154-
1 p.
artikel
75 Ras oncoproteins in human plasma from lung cancer patients and healthy controls 1996
15 1 p. 142-
1 p.
artikel
76 Recent data on cancer due to asbestos in Germany 1996
15 1 p. 140-141
2 p.
artikel
77 Resection rates and postoperative mortality in 7,899 patients with lung cancer 1996
15 1 p. 151-
1 p.
artikel
78 Results of repeated lung resection for homolateral recurrence of lung cancer after conservative resection 1996
15 1 p. 151-
1 p.
artikel
79 Sequential molecular genetic changes in lung cancer development 1996
15 1 p. 142-
1 p.
artikel
80 Single agent activity of rhizoxin in non-small-cell lung cancer: A phase II trial of the EORTC early clinical trials group 1996
15 1 p. 155-
1 p.
artikel
81 Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography 1996
15 1 p. 150-
1 p.
artikel
82 Survival following resection for lung cancer as a second primary cancer 1996
15 1 p. 150-151
2 p.
artikel
83 Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: A pilot trial 1996
15 1 p. 149-
1 p.
artikel
84 The accuracy of CT-based inhomogeneity corrections and in vivo dosimetry for the treatment of lung cancer 1996
15 1 p. 156-157
2 p.
artikel
85 The changes of the stromal elastotic framework in the growth of peripheral lung adenocarcinomas 1996
15 1 p. 146-
1 p.
artikel
86 The changing epidemiology of smoking and lung cancer histology 1996
15 1 p. 141-
1 p.
artikel
87 The clinical significance of serum soluble interleukin-2 receptors in lung cancer Yano, Tokujiro
1996
15 1 p. 79-84
6 p.
artikel
88 The effect of tobacco on lung cancer risk depends on CYP2D6 activity 1996
15 1 p. 139-140
2 p.
artikel
89 The tendency of lung cancer crude mortality rate in Ecuador. A comparative analysis with other malignant neoplasias during the decade 1984–1993 1996
15 1 p. 140-
1 p.
artikel
90 Thymopentin treatment in patients undergoing surgery for lung carcinoma: Analysis of actuarial survival 1996
15 1 p. 150-
1 p.
artikel
91 Tobacco use and its contribution to early cancer mortality with a special emphasis on cigarette smoking 1996
15 1 p. 141-
1 p.
artikel
92 Two cases of lung cancer with leptomeningeal metastasis diagnosed by gadolinium enhanced MRI 1996
15 1 p. 148-
1 p.
artikel
93 Two schedules of teniposide with or without cisplatin in advanced non-small-cell lung cancer: A randomized Study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group 1996
15 1 p. 154-
1 p.
artikel
94 Unsuspected lung cancer found in work-up for lung reduction operation 1996
15 1 p. 151-
1 p.
artikel
                             94 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland